Helen M. Boudreau - 02 Aug 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (TVRD)

Role
Director
Signature
/s/Darren DeStefano, Attorney-in-Fact
Issuer symbol
TVRD
Transactions as of
02 Aug 2023
Net transactions value
$0
Form type
4
Filing time
04 Aug 2023, 17:20:52 UTC
Previous filing
31 May 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARA Stock Option (Right to Buy) Award $0 +155,747 $0.000000 155,747 02 Aug 2023 Common Stock 155,747 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on August 2, 2023 such that the option will be fully vested and exercisable on August 2, 2026, subject to the Reporting Person's continued service to the Issuer on each such date.